ADXSD Stock Price, News & Analysis
Company Description
ADXSD (OTC: ADXSD) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $7.0M.
ADXSD stock has declined 3.8% over the past year.
This page provides a comprehensive overview of ADXSD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ADXSD (ADXSD) stock. Over the past 12 months, the stock has lost 3.8%. At a market capitalization of $7.0M, ADXSD is classified as a micro-cap stock with approximately 1.8M shares outstanding.
Latest News
ADXSD has 6 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. Key topics include acquisition, clinical trial, earnings. View all ADXSD news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ADXSD Company Profile & Sector Positioning
ADXSD (ADXSD) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ADXSD often look at related companies in the same sector, including Brainstorm Cell Therapeutics I (BCLI), TNF Pharmaceuticals (TNFA), Hcw Biologics Inc. (HCWB), Aim Immunotech (AIM), and Nucana (NCNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ADXSD's relative position within its industry.